Giripladib Uses, Dosage, Side Effects and more
Giripladib is under investigation in clinical trial NCT00396955 (A Study Comparing 4 Dose Regimens of PLA-695, Naproxen, and Placebo In Subjects With Osteoarthritis Of The Knee).
| Trade Name | Giripladib |
| Generic | Giripladib |
| Giripladib Other Names | Giripladib |
| Type | |
| Formula | C41H36ClF3N2O4S |
| Weight | Average: 745.25 Monoisotopic: 744.203641 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
